Carcinoid Syndrome
📧 Sign up to get email alerts when something new happens for Carcinoid Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome [Phase 2]
Phase 2 study of paltusotine in patients with carcinoid syndrome completed with results posted, detailing safety, pharmacokinetics, and dose…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm [Phase 2]
Phase 2 AMT-PET monitoring study evaluating telotristat etiprate in participants with metastatic neuroendocrine neoplasms has completed and …
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO
TerSera Therapeutics completed a real-world evidence study evaluating patient-reported outcomes for XERMELO (telotristat ethyl) in carcinoid…
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs [Phase 2]
Phase 2 clinical trial update evaluating an amino acid–based medical food for diarrhea in neuroendocrine tumors, including carcinoid syndrom…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy [Phase 2]
Phase 2 clinical trial update investigating peptide receptor radiotargeted therapy for carcinoid heart disease and carcinoid syndrome/tumor.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation [Phase 4]
Phase 4 trial update for Sandostatin (octreotide LAR) evaluating potential clinical improvement via receptor occupation optimization in neur…
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms [Phase 3]
Phase 3 trial update on telotristat etiprate showing expanded treatment for patients with carcinoid syndrome symptoms; results completed wit…
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy [Phase 2]
Phase 2 trial evaluating telotristat etiprate (LX1606) for symptomatic carcinoid syndrome not controlled by stable-dose octreotide; study co…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects [Phase 1]
Phase 1 study evaluating whether omeprazole and famotidine affect the absorption of telotristat ethyl in healthy subjects; the study is comp…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome [Phase 2]
Phase 2 trial of telotristat etiprate (LX1606) in symptomatic carcinoid syndrome completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Telotristat Etiprate for Carcinoid Syndrome Therapy [Phase 3]
A Phase 3 trial evaluating Telotristat Etiprate for carcinoid syndrome has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) [Phase 3]
Phase 3 TELESTAR trial evaluating telotristat etiprate for carcinoid syndrome completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome [Phase 3]
Phase 3 trial evaluating efficacy and safety of Somatuline Depot (lanreotide) for carcinoid syndrome has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome [Phase 2]
Phase 2 trial assessing different doses of BIM 23A760 in carcinoid syndrome was terminated with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome [Phase 2]
A Phase 2 trial of above-label octreotide LAR for insufficiently controlled carcinoid syndrome in neuroendocrine carcinoma was terminated, w…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males [Phase 1]
Open-label Phase 1 study assessing absorption, metabolism, and excretion of radiolabeled telotristat etiprate in male participants with carc…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome [Phase 1, Phase 2]
The document reports pharmacokinetics, efficacy and safety results from phase 1/2 studies of an octreotide implant in patients with carcinoi…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease [Phase 3]
Phase 3 trial comparing pasireotide long-acting release to octreotide long-acting release in patients with metastatic carcinoid disease; the…
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: Effects of Serotonin Excess on Bone in Carcinoid Syndrome
A completed clinical trial investigated how serotonin excess affects bone health in patients with carcinoid syndrome.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor [Phase 3]
A Phase 3 trial evaluating the combination of everolimus and octreotide in patients with advanced carcinoid tumor has completed and posted r…